admin
Pharma and nutraceutical brands face a strategic choice as they grow: keep outsourcing production to third party manufacturers or invest in their own facility. There is no universal answer, but a structured comparison makes the decision much clearer.
The Case for Third Party Manufacturing
- No large upfront capital investment
- Faster product launches using existing licensed facilities
- Access to multiple dosage forms through different partners
- Flexibility to scale volumes up or down
The Case for an Own Facility
- Full control over quality, scheduling and costs
- Better margins at high, stable volumes
- Stronger positioning for regulated market registrations
- Asset value for future investment or acquisition
Questions to Ask Before Deciding
- Are your volumes large and predictable enough to keep a plant busy?
- Do you have the capital and management bandwidth for a multi year project?
- Which markets require site specific registrations or inspections?
- How important is speed to market for your next launches?
Many successful companies use a hybrid model: core high volume products in their own plant and specialised or new products with trusted contract partners.
Key takeaway
Start with contract manufacturing to validate products and markets, then build your own capacity once volumes and margins justify the investment.
